1.59
-0.01 (-0.63%)
| Penutupan Terdahulu | 1.60 |
| Buka | 1.59 |
| Jumlah Dagangan | 27,567 |
| Purata Dagangan (3B) | 102,983 |
| Modal Pasaran | 67,369,888 |
| Harga / Pendapatan (P/E Ke hadapan) | 11.70 |
| Harga / Jualan (P/S) | 11.46 |
| Harga / Buku (P/B) | 1.05 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 Nov 2025 |
| Margin Operasi (TTM) | -749.51% |
| EPS Cair (TTM) | -0.770 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 1.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 8.19% |
| Nisbah Semasa (MRQ) | 4.36 |
| Aliran Tunai Operasi (OCF TTM) | -25.60 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -13.62 M |
| Pulangan Atas Aset (ROA TTM) | -58.16% |
| Pulangan Atas Ekuiti (ROE TTM) | -113.95% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | InspireMD Inc. | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | 1.5 |
| Volatiliti Harga | 3.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.5 |
| Purata | 0.50 |
|
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 30.14% |
| % Dimiliki oleh Institusi | 42.29% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Rosalind Advisors, Inc. | 30 Sep 2025 | 3,905,743 |
| Velan Capital Investment Management Lp | 30 Sep 2025 | 2,143,698 |
| Pura Vida Investments, Llc | 30 Sep 2025 | 450,517 |
| Huntleigh Advisors, Inc. | 30 Sep 2025 | 264,004 |
| Affiance Financial, Llc | 30 Sep 2025 | 250,370 |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| BERMAN MICHAEL | 1.59 | - | 88,053 | 140,004 |
| COHEN RAYMOND W | 1.59 | - | 44,030 | 70,008 |
| DEAREN DANNY L. | 1.59 | - | 44,030 | 70,008 |
| GLEASON SHANE THOMAS | 1.59 | - | 453,390 | 720,890 |
| LAWLESS MICHAEL A | 1.59 | - | 226,695 | 360,445 |
| ROUBIN GARY S | 1.59 | - | 88,053 | 140,004 |
| SLOSMAN MARVIN | 1.59 | - | 1,114,792 | 1,772,519 |
| STUKA PAUL | 1.59 | - | 132,076 | 210,001 |
| TOMMASOLI ANDREA | 1.59 | - | 226,695 | 360,445 |
| WARD SCOTT R. | 1.59 | - | 88,053 | 140,004 |
| Jumlah Keseluruhan Kuantiti Bersih | 2,505,867 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 3,984,329 | |||
| Purata Pembelian Keseluruhan ($) | 1.59 | |||
| Purata Jualan Keseluruhan ($) | - | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| BERMAN MICHAEL | Pengarah | 14 Jan 2026 | Diperolehi (+) | 88,053 | 1.59 | 140,004 |
| COHEN RAYMOND W | Pengarah | 14 Jan 2026 | Diperolehi (+) | 44,030 | 1.59 | 70,008 |
| DEAREN DANNY L. | Pengarah | 14 Jan 2026 | Diperolehi (+) | 44,030 | 1.59 | 70,008 |
| GLEASON SHANE THOMAS | Pegawai | 14 Jan 2026 | Diperolehi (+) | 453,390 | 1.59 | 720,890 |
| LAWLESS MICHAEL A | Pegawai | 14 Jan 2026 | Diperolehi (+) | 226,695 | 1.59 | 360,445 |
| ROUBIN GARY S | Pengarah | 14 Jan 2026 | Diperolehi (+) | 88,053 | 1.59 | 140,004 |
| SLOSMAN MARVIN | Pegawai | 14 Jan 2026 | Diperolehi (+) | 1,114,792 | 1.59 | 1,772,519 |
| STUKA PAUL | Pengarah | 14 Jan 2026 | Diperolehi (+) | 132,076 | 1.59 | 210,001 |
| TOMMASOLI ANDREA | Pegawai | 14 Jan 2026 | Diperolehi (+) | 226,695 | 1.59 | 360,445 |
| WARD SCOTT R. | Pengarah | 14 Jan 2026 | Diperolehi (+) | 88,053 | 1.59 | 140,004 |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 12 Jan 2026 | Pengumuman | InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC) |
| 24 Nov 2025 | Pengumuman | Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting |
| 21 Nov 2025 | Pengumuman | InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 19 Nov 2025 | Pengumuman | InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference |
| 04 Nov 2025 | Pengumuman | InspireMD Reports Third Quarter 2025 Financial Results |
| 03 Nov 2025 | Pengumuman | InspireMD Names Peter A. Soukas, M.D., as Chief Medical Officer |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |